The role of thymic stromal lymphopoietin in cutaneous disorders.

Abstract

Thymic Stromal Lymphopoietin (TSLP) is an important cytokine that invokes early immune responses. TSLP, an IL-7-like cytokine encoded by the TSLP gene, activates JAK1 and JAK2 signaling pathways, stimulating dendritic cells to induce inflammatory Th2 cells. This cytokine is associated with pruritus in various cutaneous disorders, particularly atopic dermatitis. Varying levels of the cytokine TSLP have been demonstrated in studies of different cutaneous disorders. Pharmacological treatment targeting TSLP has been explored recently, particularly in the realm of atopic dermatitis.This review explores the relation of TSLP to cutaneous diseases, highlighting its potential as a biomarker for monitoring disease progression in discoid lupus erythematosus (DLE). The pharmacological therapy involving TSLP is discussed, along with the potential role of TSLP promotion in the treatment of alopecia areata. This overview examines the background, structure, and functions of TSLP, with a focus on its association with cutaneous disorders and a special focus on the impact of the atopic march.

• Authors: Alexander J Jafari, Melissa Rivera, Adelaide A Hebert
• Journal: Archives of dermatological research (Arch Dermatol Res) Vol. 316 Issue 5 Pg. 123 (Apr 17 2024) ISSN: 1432-069X [Electronic] Germany
• PMID: 38630260 (Publication Type: Journal Article, Review)
• Copyright: © 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Chemical References

• Cytokines
• Thymic Stromal Lymphopoietin

Topics

• Humans
• Alopecia Areata
• Cytokines
• Dermatitis, Atopic
• Skin Diseases (metabolism, pathology)
• Thymic Stromal Lymphopoietin (metabolism)